Development of a novel fluorescence polarization-based assay for studying the β-catenin/Tcf4 interaction

Journal of Biomolecular Screening

Volumn 17, Issue 4, 2012, Pages 530-534

  Tian, Wang ^a,b   Xu, Yan ^a,b   Han, Xiaofeng ^a,b   Duggineni, Srinivas ^a,b   Han, Xiaobing ^a,b   Huang, Ziwei ^a,b   An, Jing ^a,b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

catenin; competitive binding assay; fluorescence polarization; high throughput screening; T cell factor

Indexed keywords

BETA CATENIN; FLUORESCEIN ISOTHIOCYANATE; T CELL FACTOR PROTEIN;

ARTICLE; CONTROLLED STUDY; FLUORESCENCE POLARIZATION IMMUNOASSAY; HIGH THROUGHPUT SCREENING; HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; BINDING, COMPETITIVE; DRUG EVALUATION, PRECLINICAL; FLUORESCENCE POLARIZATION; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; TRANSCRIPTION FACTORS;

EID: 84858975538     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057111429745     Document Type: Article

References (15)

1. Barker, N.; Clevers, H. Mining the Wnt Pathway for Cancer Therapeutics. Nat. Rev. Drug Discov. 2006, 5, 997-1014. (Pubitemid 44835127)
2. Clevers, H. Wnt/β-Catenin Signaling in Development and Disease. Cell 2006, 127, 469-480.
3. Moon, R. T.; Kohn, A. D.; Ferrari, G. V. D.; Kaykas, A. WNT and β-catenin Signalling: Diseases and Therapies. Nat. Rev. Genet. 2004, 5, 691-701. (Pubitemid 39150127)
4. van de Wetering, M.; Sancho, E.; Verweij, C.; de Lau, W.; Oving, I.; Hurlstone, A.; van der Horn, K.; Batlle, E.; Coudreuse, D.; Haramis, A.; et al. The Beta-Catenin-TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells. Cell 2002, 111, 241-250.
5. Poy, F.; Lepourcelet, M.; Shivdasani, R. A.; Eck, M. J. Structure of a Human Tcf4-Beta-Catenin Complex. Nat. Struct. Biol. 2001, 8, 1053-1057.
6. Lepourcelet, M.; Chen, Y. P.; France, D. S.; Wang, H.; Crews, P.; Petersen, F.; Bruseo, C.; Wood, A. W.; Shivdasani, R. A. Small-Molecule Antagonists of the Oncogenic Tcf-Beta-Catenin Protein Complex. Cancer Cell 2004, 5, 91-102. (Pubitemid 38121599)
7. Huang, X.; Aulabaugh, A. Application of Fluorescence Polarization in HTS Assays. Methods Mol. Biol. 2009, 565, 127-143.
8. Mitra, S.; Duggineni, S.; Koolpe, M.; Zhu, X.; Huang, Z.; Pasquale, E. B. Structure-Activity Relationship Analysis of Peptides Targeting the EphA2 Receptor. Biochemistry 2010, 49, 6687-6695.
9. Kawamoto, S. A.; Thompson, A. D.; Coleska, A.; Nikolovska- Coleska, Z.; Yi, H.; Wang, S. Analysis of the Interaction of BCL9 with β-Catenin and Development of Fluorescence Polarization and Surface Plasmon Resonance Binding Assays for This Interaction. Biochemistry 2009, 48, 9534-9541.
10. Kim, J.; Felts, S.; Llauger, L.; He, H.; Huezo, H.; Rosen, N.; Chiosis, G. Development of a Fluorescence Polarization Assay for the Molecular Chaperone Hsp90. J. Biomol. Screen. 2004, 9, 375-381.
11. Fasolini, M. Hot Spots in Tcf4 for the Interaction with Beta-Catenin. J. Biol. Chem. 2003, 278, 21092-21098. (Pubitemid 36806421)
12. Graham, T. A.; Weaver, C.; Mao, F.; Kimelman, D.; Xu, W. Crystal Structure of a Beta-Catenin-Tcf Complex. Cell 2000, 103, 885-896.
13. Gail, R. Systematic Peptide Array-based Delineation of the Differential Beta-Catenin Interaction with Tcf4, E-Cadherin, and Adenomatous Polyposis Coli. J. Biol. Chem. 2005, 280, 7107-7117. (Pubitemid 40341267)
14. Huber, A. H.; Weis, W. I. The Structure of the Beta-Catenin/E-Cadherin Complex and the Molecular Basis of Diverse Ligand Recognition by Beta-Catenin. Cell 2001, 105, 391-402. (Pubitemid 32455345)
15. Xing, Y.; Clements, W. K.; Le, T. I.; Hinds, T. R.; Stenkamp, R.; Kimelman, D.; Xu, W. Crystal Structure of a Beta-Catenin/APC Complex Reveals a Critical Role for APC Phosphorylation in APC Function. Mol. Cell. 2004, 15, 523-533. (Pubitemid 39141780)